Skip to main content
. Author manuscript; available in PMC: 2019 Feb 13.
Published in final edited form as: BJU Int. 2010 Nov 9;108(1):56–60. doi: 10.1111/j.1464-410X.2010.09838.x

TABLE 1.

Clinical characteristics of 1877 patients

No. of patients %
D’Amico risk
 Low 857 45.7
 Intermediate 703 37.5
 High 316 16.8
Biopsy Gleason score
 2–6 1151 61.3
 7 563 30.0
 8–10 163 8.7
Prostate-specific antigen (ng/mL)
 ≤4 310 16.5
 4.1–10 1263 67.3
 10.1–20 239 12.7
 >20 65 3.5
Clinical stage (1992 TNM)
 T1a/b 16 0.9
 T1c 1035 55.1
 T2a 495 26.4
 T2b 201 10.7
 T2c 119 6.3
 T3a 11 0.6